Project Title:  Membrane Protein Nanocrystallography

Post Doc Location: AstraZeneca Mölndal, Sweden



Description of Opportunity: We have an exciting opportunity for a Ph.D. 
scientist to join the Discovery Sciences department, a global organisation 
supporting all innovative Medicines Units (iMeds) within AstraZeneca. The 
project Membrane Protein Nanocrystallography (NanoMem) is part of the Marie 
Curie Initial Training Network funded by the European Commission and is a close 
collaboration between ten different laboratories in Europe from both 
Universities and Industries. The aim is to exploit synchrotron based 
micro-focus X-ray beams to address challenging diffraction studies from small 
membrane protein crystals and the revolutionary new possibilities created by 
the Xray Free Electron lasers which combine ultrafast X-ray pulses with high 
brilliance focussing capabilities. NanoMem will exploit the new scientific 
opportunities created by these technical capabilities through close 
collaboration between structural biologists, beamline engineers, software 
developers and industrial partners like AstraZeneca and others.



NanoMem is an interdisciplinary training network incorporating membrane protein 
crystallisation, microcrystal and nanocrystal preparation and handling 
technologies, microfocus diffraction, software development, structure based 
drug design and serial femtosecond crystallography. The postdoc is expected to 
contribute to the overall objectives of the Marie Curie Initial Training 
Network NanoMem through networking, secondments and joint experiments with the 
other partners involved.

The role's major responsibilities

Develop and explore approaches to prepare small well diffracting membrane 
protein crystals

Show strong initiative in developing ideas and bringing them forward to 
functional use within AstraZeneca and within the NanoMem network

Communicate results both within AstraZeneca, the NanoMem Collaboration and 
externally at meetings and through publications

Develop skills in and understanding of the drug discovery process

Work collaboratively with other experts within Discovery Sciences, the iMED 
organisation and within the NanoMem network



Minimum experience

A recent PhD in one or more of the following areas:

Biochemistry focussing on membrane proteins

Structural Biology with an interest in membrane protein

Preferred experience/requirements

Experience working with membrane protein expression and purification

Experience in crystallization/X-ray crystallography

Ability to design and carry out research independently

Strong written and oral communication skills

Motivation to work in a multidisciplinary and international environment is 
fundamental to this position

For this position the eligible researcher must not have lived in Sweden more 
than 12 months for the last three years



More Information / Main Supervisors:

AZ: Margareta Ek, Ph.D. Associate Principal Scientist, Structure & Biophysics, 
Discovery Sciences. margareta.e...@astrazeneca.com

Arjan Snijder,Ph. D. Associate Principal Scientist, Reagents and Assay 
Development, Discovery Sciences. arjan.snij...@astrazeneca.com



Apply online no later than November 14, 2012. To find the ad, search for job 
number: "MOL000000VP" at 
http://www.astrazeneca.se/karriar/ledig-tjnstervacancies/job-search--en Please 
refer to the job number and the title in all correspondence.









_____________________________________________________________________________________________



Patrik Johansson

Associate Principal Scientist

AstraZeneca, R&D | Discovery Sciences

Pepparedsleden 1, 43183 Mölndal, SWEDEN

P +46 31 70 64570, F +46 31 77 63792


--------------------------------------------------------------------------
Confidentiality Notice: This message is private and may contain confidential 
and proprietary information. If you have received this message in error, please 
notify us and remove it from your system and note that you must not copy, 
distribute or take any action in reliance on it. Any unauthorized use or 
disclosure of the contents of this message is not permitted and may be unlawful.
 

Reply via email to